EMERYVILLE, Calif. and CULVER CITY, Calif.: EMERYVILLE, Calif. and CULVER CITY, Calif., Jan. 3, 2022 /PRNewswire/ — Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-Market™ operating platform, and ImmunityBio (Nasdaq: IBRX), a clinical-stage immunotherapy company, today announced the completion of…
News Ticker
- [ December 6, 2023 ] CatalYm’s efforts to revive obesity target for solid tumors yield positive PhIIa results Los Angeles Biotech News
- [ December 6, 2023 ] Latino Alternative Television (LATV) Partners with the Huntsman Mental Health Institute and the Ad Council for Latino Men’s Mental Health Event Los Angeles Biotech News
- [ December 6, 2023 ] Deep 6 AI Expands Its Recruitment Acceleration Solution for Life Sciences to Shorten the Time from Determining Patient Eligibility to Enrollment Los Angeles Biotech News
- [ December 6, 2023 ] Lab operation Manager – MolBreeding biotechnology LLC – Irvine, CA Los Angeles Biotech Jobs
- [ December 6, 2023 ] SaniSure earns EcoVadis Silver Rating, recognizing strong commitment to sustainability Los Angeles Biotech News
Copyright © 2023 Biotech Networks, LLC
